In the context of an interview by the well-known magazine, Tobacco Journal International (TJI), the management of Valeo laboratories was asked about the future prospects of our industry, and in particular about the patented nicotine substitute BioNic.
BioNic, an in-house development of Valeo laboratories, is a best-seller, particularly within countries where nicotine products have generally been stigmatised with an imposed sales ban. BioNic simulates the nicotine that is normally found in e-liquid by exclusively using ingredients active in plants, which are approved as foodstuffs. These plant-based active ingredients give users a very similar feeling to the well-known nicotine, due to the activation of specific receptors/sensors upon inhaling the vapour.
You can see the full interview in English: